Search Results - "Leperlier, F"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Female obesity does not impact live birth rate after frozen-thawed blastocyst transfer by Prost, E, Reignier, A, Leperlier, F, Caillet, P, Barrière, P, Fréour, T, Lefebvre, T

    Published in Human reproduction (Oxford) (28-04-2020)
    “…Abstract STUDY QUESTION Does female obesity affect live birth rate after frozen-thawed blastocyst transfer? SUMMARY ANSWER Live birth rate was not…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Pre-implantation genetic testing: Comparison between cleavage stage and blastocyst biopsy by Bacus, J, Lammers, J, Loubersac, S, Lefebvre, T, Leperlier, F, Barriere, P, Fréour, T, Reignier, A

    “…Preimplantation genetic testing (PGT) refers to the set of techniques for testing whether embryos obtained through in vitro fertilization have genetic defect…”
    Get full text
    Journal Article
  5. 5

    Abstract P3-14-03: PRESAGE : Prospective multicenter feasibility study of fertility preservation before neoadjuvant or adjuvant chemotherapy for breast cancer: Preliminary results by Bordes, V, Frick, C, Leperlier, F, Dezellus, A, De Blay, P, Maigne, F, Sauterey, B, Augereau, P, Lefeuvre-Plesse, C, Campone, M, Mirallie, S

    Published in Cancer research (Chicago, Ill.) (15-02-2018)
    “…Abstract Background: Breast cancer is the most frequent form of cancer for young women. For these patients, breast cancer is generally more aggressive and…”
    Get full text
    Journal Article
  6. 6

    Abstract P4-16-02: Fertility preservation before neoadjuvant or adjuvant chemotherapy for breast cancer: Final results of PRESAGE trial by Bordes, V, Palpacuer, C, FRICK, C, Leperlier, F, Dezellus, A, De Blay, P, Delay, F, Sauterey, B, Augereau, P, Duros, S, Lefeuvre-Plesse, C, Lavau, S, Durand, LM, Mouret, MA, Gremeau, AS, Campone, M, Mirallie, S

    Published in Cancer research (Chicago, Ill.) (15-02-2019)
    “…Abstract Background: Breast cancer is the most frequent form of cancer in young women. For these patients, breast cancer is generally more aggressive and…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The use of GnRH antagonists in ovarian stimulation for intrauterine inseminations: is there any interest? by Pasquier, M, Maitrot, L, Leperlier, F, Dehghani, C, Snaifer, E, Durnerin, I-C, Hugues, J-N

    Published in Gynécologie, obstétrique & fertilité (01-06-2008)
    “…The use of the GnRH antagonists during ovarian stimulation for intrauterine insemination is relatively recent. The primary aim was to improve the timing of the…”
    Get full text
    Journal Article
  9. 9

    Déficit en cytochrome P450 oxydoréductase : à propos d’un cas. Implication dans la biosynthèse des stéroïdes et enjeu de la transition endocrinologie pédiatrique-endocrinologie adulte by Lugat, A., Morel, Y., Baron, S., Isidor, B., Bouqin, R., Leperlier, F., Cariou, B., Drui, D.

    Published in Annales d'endocrinologie (01-09-2017)
    “…Le déficit en cytochrome P450 oxydoréductase (mutation POR) est une forme particulière d’hyperplasie congénitale des surrénales entraînant des déficits…”
    Get full text
    Journal Article
  10. 10
  11. 11

    FEMALE (IN)FERTILITY by Kanta Goswami, S., Banerjee, S., Saha, P., Chakraborty, P., Kabir, S. N., Karimzadeh, M. A., Mohammadian, F., Mashayekhy, M., Saldeen, P., Kallen, K., Karlstrom, P. O., Rodrigues-Wallberg, K. A., Salerno, A., Nazzaro, A., Di Iorio, L., Marino, S., Granato, C., Landino, G., Pastore, E., Ghoshdastidar, B., Chakraborty, C., Ghoshdastidar, B. N., Ghoshdastidar, S., Partsinevelos, G. A., Papamentzelopoulou, M., Mavrogianni, D., Marinopoulos, S., Dinopoulou, V., Theofanakis, C., Anagnostou, E., Loutradis, D., Franz, C., Nieuwland, R., Montag, M., Boing, A., Rosner, S., Germeyer, A., Strowitzki, T., Toth, B., Mohamed, M., Vlismas, A., Sabatini, L., Caragia, A., Collins, B., Leach, A., Zosmer, A., Al-Shawaf, T., Beyhan, Z., Fisch, J. D., Danner, C., Keskintepe, L., Aydin, Y., Ayca, P., Oge, T., Hassa, H., Papanikolaou, E., Pados, G., Grimbizis, G., Bili, H., Karastefanou, K., Fatemi, H., Kyrou, D., Humaidan, P., Tarlatzis, B., Gungor, F., Karamustafaoglu, B., Iyibozkurt, A. C., Ozsurmeli, M., Bastu, E., Buyru, F., Di Emidio, G., Vitti, M., Mancini, A., Baldassarra, T., D'Alessandro, A. M., Polsinelli, F., Tatone, C., Leperlier, F., Lammers, J., Dessolle, L., Lattes, S., Barriere, P., Freour, T., Elodie, P., Assou, S., Van den Abbeel, E., Arce, J. C., Hamamah, S., Dechaud, H., Haouzi, D., Tiplady, S., Johnson, S., Jones, G., Ledger, W., Eizadyar, N., Ahmad Nia, S., Seyed Mirzaie, M., Azin, S. A., Yazdani Safa, M., Onaran, Y.

    Published in Human reproduction (Oxford) (01-07-2012)
    “…Abstract only…”
    Get full text
    Journal Article
  12. 12

    Utilisation des antagonistes de la GnRH au cours des stimulations pour inséminations intra-utérines : y a-t-il un intérêt ? by Pasquier, M., Maitrot, L., Leperlier, F., Dehghani, C., Snaifer, E., Durnerin, I.-C., Hugues, J.-N.

    Published in Gynécologie, obstétrique & fertilité (01-06-2008)
    “…L’utilisation des antagonistes de la GnRH au cours des cycles d’insémination intra-utérine est relativement récente. Son premier objectif a été de permettre…”
    Get full text
    Journal Article